Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Mazurek

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Neurology|April 7, 2011
Treatment of conversion disorder in the 21st century: have we moved beyond the couch?Patricia I Rosebush, Michael F Mazurek
Schizophrenia Bulletin|December 9, 2009
Catatonia and its treatmentPatricia I Rosebush, Michael F Mazurek
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 26, 2004
Recognizing neuroleptic malignant syndromePatricia I Rosebush, Sarah Garside, Michael F Mazurek
World Journal of Psychiatry|January 13, 2017
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiologySean A Rasmussen, Michael F Mazurek, Patricia I Rosebush
Journal of Clinical Psychopharmacology|December 28, 2016
The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side EffectsSean A Rasmussen, Patricia I Rosebush, Michael F Mazurek
Psychosomatics|March 25, 2010
Treating psychiatric illness in patients with mitochondrial disordersRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
The Journal of Neuropsychiatry and Clinical Neurosciences|December 1, 2006
The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenonRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
Human Psychopharmacology|September 28, 2017
Does early antipsychotic response predict long-term treatment outcome?Sean A Rasmussen, Patricia I Rosebush, Michael F Mazurek
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2010
Neuroleptic malignant syndrome: a neuroimmunologic hypothesisRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
Synapse (New York, N.Y.)|November 29, 2011
The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleusLindsey MacGillivray, Katelyn B Reynolds, Patricia I Rosebush, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Neurology|April 7, 2011
Treatment of conversion disorder in the 21st century: have we moved beyond the couch?Patricia I Rosebush, Michael F Mazurek
Schizophrenia Bulletin|December 9, 2009
Catatonia and its treatmentPatricia I Rosebush, Michael F Mazurek
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 26, 2004
Recognizing neuroleptic malignant syndromePatricia I Rosebush, Sarah Garside, Michael F Mazurek
World Journal of Psychiatry|January 13, 2017
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiologySean A Rasmussen, Michael F Mazurek, Patricia I Rosebush
Journal of Clinical Psychopharmacology|December 28, 2016
The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side EffectsSean A Rasmussen, Patricia I Rosebush, Michael F Mazurek
Psychosomatics|March 25, 2010
Treating psychiatric illness in patients with mitochondrial disordersRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
The Journal of Neuropsychiatry and Clinical Neurosciences|December 1, 2006
The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenonRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
Human Psychopharmacology|September 28, 2017
Does early antipsychotic response predict long-term treatment outcome?Sean A Rasmussen, Patricia I Rosebush, Michael F Mazurek
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2010
Neuroleptic malignant syndrome: a neuroimmunologic hypothesisRebecca E Anglin, Patricia I Rosebush, Michael F Mazurek
Synapse (New York, N.Y.)|November 29, 2011
The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleusLindsey MacGillivray, Katelyn B Reynolds, Patricia I Rosebush, et al.
Pageof 2